| |
| |
|
| Insider
Information: |
Colowick Alan |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
214,788 |
|
|
Indirect Shares
|
3,028 |
|
|
| Direct
Value |
$295,732 |
|
|
|
Indirect Value
|
$11,476 |
|
|
| Total
Shares |
217,816 |
|
|
| Total
Value |
$307,208 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Molecular Templates, Inc. |
MTEM |
Officer |
2005-02-03 |
151,800 |
|
0 |
Premium* |
|
|
Geron Corporation |
GERN |
President, Oncology |
2007-10-16 |
49,482 |
2008-01-02 |
3,028 |
Premium* |
|
|
Principia Biopharma Inc |
PRNB |
Director |
2020-07-01 |
0 |
2020-05-01 |
0 |
Premium* |
|
|
Personalis, Inc. |
PSNL |
Director |
2022-05-17 |
13,506 |
2021-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PSNL |
Personalis, Inc. |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,770 |
13,506 |
0 |
- |
|
| PSNL |
Personalis, Inc. |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,736 |
2,736 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-07-01 |
4 |
AS |
$60.00 |
$450,000 |
D/D |
(7,500) |
0 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-07-01 |
4 |
OE |
$4.54 |
$34,065 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-05-05 |
4 |
AS |
$60.00 |
$399,600 |
D/D |
(6,660) |
0 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-05-05 |
4 |
OE |
$4.54 |
$30,250 |
D/D |
6,660 |
6,660 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-05-01 |
4 |
AS |
$60.07 |
$50,457 |
D/D |
(840) |
0 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-05-01 |
4 |
OE |
$4.54 |
$3,815 |
D/D |
840 |
840 |
0 |
- |
|
| GERN |
Geron Corporation |
President, Oncology |
• – – |
2008-01-02 |
4 |
A |
$5.73 |
$15,500 |
I/I |
2,705 |
3,028 |
0 |
- |
|
| GERN |
Geron Corporation |
President, Oncology |
• – – |
2007-10-16 |
4 |
D |
$7.78 |
$27,814 |
D/D |
(3,575) |
49,482 |
0 |
- |
|
| GERN |
Geron Corporation |
President, Oncology |
• – – |
2007-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,734 |
53,057 |
0 |
- |
|
| GERN |
Geron Corporation |
President, Oncology |
• – – |
2007-01-03 |
4 |
A |
$8.76 |
$2,829 |
I/I |
323 |
40,323 |
0 |
- |
|
| GERN |
Geron Corporation |
President, OncologyOfficer |
• – – |
2006-10-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,000 |
|
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Medical OfficerOfficer |
• – – |
2005-02-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
151,800 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
